Both in Pharmaceuticals
Ligand Pharmaceuticals vs PTC Therapeutics
Over the past year LGND returned +63.8% and PTCT returned −9.3%; their daily moves had a correlation of 0.35.
LGND +63.8% PTCT −9.3%Growth of $1, one year, split-adjusted
| Metric | LGND | PTCT |
|---|---|---|
| Price | $303.53 | $60.59 |
| Market cap | $6.05B | $5.06B |
| Today | −1.39% | −3.89% |
| 1 month | +1.5% | −2.7% |
| 6 months | +31.2% | −11.2% |
| Year to date | +60.5% | −20.2% |
| 1 year | +63.6% | −8.9% |
| Revenue growth (YoY) | +33.7% | +101.5% |
| Gross margin | 82.2% | 94.5% |
| Net margin | 76.2% | 23.2% |
| P/E (TTM) | 30.7× | — |
| Price / sales | 20.8× | 5.0× |
| Net cash | $244.1M | $1.63B |
| Dividend yield | — | — |
| Volatility (60d) | 28.8% | 40.1% |
| Short % of float | 14.2% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).